Neoepitope vaccine and minnune stimulant combinations and methods

• 收藏
• 分享

专利权人:

NantCell; Inc.

发明人:

Shahrooz Rabizadeh,Patrick Soon-Shiong

申请号：

US16390946

公开号：

US20200016254A1

申请日:

2019.04.22

申请国别(地区):

US

年份:

2020

代理人:

摘要：

Cancer is treated via a coordinated treatment regimen that use various compounds and compositions that employ prime-boost vaccination in combination with immune modulatory treatment and biasing of an immune response towards a Th1 profile.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/